Scientific Research Team

The Scientific Research Team at Oric Pharmaceuticals focuses on elucidating the mechanisms of cancer therapy resistance and developing innovative treatments to counteract these mechanisms. This team conducts advanced preclinical and clinical research, including in vivo pharmacology, bioinformatics analyses, and medicinal chemistry, to support the discovery and optimization of novel oncology therapeutics. Their efforts are crucial in advancing ORIC’s lead assets, such as ORIC-101, and expanding the company's pipeline of resistance-targeting cancer treatments.